Kageyama S - Search Results

1

Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma.

Uejima D, Nishijo K, Kajita Y, Ishibe T, Aoyama T, Kageyama S, Iwaki H, Nakamura T, Iida H, Yoshiki T, Toguchida J. Uejima D, et al. Among authors: kageyama s. Anticancer Res. 2011 Apr;31(4):1297-305. Anticancer Res. 2011. PMID: 21508379

2

A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma.

Kageyama S, Iwaki H, Inoue H, Isono T, Yuasa T, Nogawa M, Maekawa T, Ueda M, Kajita Y, Ogawa O, Toguchida J, Yoshiki T. Kageyama S, et al. Proteomics Clin Appl. 2007 Feb;1(2):192-9. doi: 10.1002/prca.200600468. Epub 2007 Jan 22. Proteomics Clin Appl. 2007. PMID: 21136669

3

Multiple NF-Y-binding CCAAT boxes are essential for transcriptional regulation of the human C7orf24 gene, a novel tumor-associated gene.

Ohno Y, Hattori A, Ueda M, Kageyama S, Yoshiki T, Kakeya H. Ohno Y, et al. Among authors: kageyama s. FEBS J. 2011 Nov;278(21):4088-99. doi: 10.1111/j.1742-4658.2011.08314.x. Epub 2011 Sep 26. FEBS J. 2011. PMID: 21883928 Free article.

4

Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.

Kageyama S, Hanada E, Ii H, Tomita K, Yoshiki T, Kawauchi A. Kageyama S, et al. Biomed Res Int. 2015;2015:345219. doi: 10.1155/2015/345219. Epub 2015 Aug 3. Biomed Res Int. 2015. PMID: 26339607 Free PMC article. Review.

5

Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis.

Zeng Y, Wu XX, Homma Y, Yoshimura N, Iwaki H, Kageyama S, Yoshiki T, Kakehi Y. Zeng Y, et al. Among authors: kageyama s. J Urol. 2007 Oct;178(4 Pt 1):1322-7; discussion 1327. doi: 10.1016/j.juro.2007.05.125. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698128

6

Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.

Kataoka A, Yuasa T, Kageyama S, Iwaki H, Higuchi K, Tanaka T, Okada Y, Yoshiki T. Kataoka A, et al. Among authors: kageyama s. Oncol Rep. 2005 Apr;13(4):597-600. Oncol Rep. 2005. PMID: 15756429

7

Upregulation of tissue and urinary uroplakin mRNA in patients with vesicoureteral reflux.

Iwaki H, Kageyama S, Yoshiki T. Iwaki H, et al. Among authors: kageyama s. Int J Urol. 2014 Mar;21(3):347. doi: 10.1111/iju.12265. Epub 2013 Aug 28. Int J Urol. 2014. PMID: 24033750 No abstract available.

8

A GGCT fluorogenic probe: design, synthesis and application to cancer-related cells.

Yoshiya T, Ii H, Tsuda S, Kageyama S, Yoshiki T, Nishiuchi Y. Yoshiya T, et al. Among authors: kageyama s. Org Biomol Chem. 2015 Mar 21;13(11):3182-5. doi: 10.1039/c5ob00086f. Org Biomol Chem. 2015. PMID: 25651484

9

Proteome research in urothelial carcinoma.

Kageyama S, Isono T, Iwaki H, Hanada E, Tomita K, Yoshida T, Yoshiki T, Kawauchi A. Kageyama S, et al. Int J Urol. 2015 Jul;22(7):621-8. doi: 10.1111/iju.12793. Epub 2015 May 5. Int J Urol. 2015. PMID: 25944546 Review.

10

Design of fluorogenic probes and fluorescent-tagged inhibitors for γ-glutamyl cyclotransferase.

Yoshiya T, Ii H, Tsuda S, Mochizuki M, Kageyama S, Yoshiki T. Yoshiya T, et al. Among authors: kageyama s. J Pept Sci. 2017 Jul;23(7-8):618-623. doi: 10.1002/psc.2984. Epub 2017 Feb 15. J Pept Sci. 2017. PMID: 28198125 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

872 results

Search Page

Filters